Veterinary Medicines

Depo-Medrone V 40 40 mg/ml Zawiesina do wstrzykiwań

Authorised
  • Methylprednisolone acetate
Download as PDF

Product identification

Medicine name:
Depo-Medrone V 40 40 mg/ml Zawiesina do wstrzykiwań
Active substance:
  • Methylprednisolone acetate
Target species:
  • Horse
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intraarticular use
  • Intrabursal use

Product details

Active substance and strength:
  • Methylprednisolone acetate
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        5
        week
    • Dog
    • Cat
  • Intraarticular use
    • Horse
      • Meat and offal
        5
        week
    • Dog
    • Cat
  • Intrabursal use
    • Horse
      • Meat and offal
        5
        week
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pfizer Manufacturing Belgium
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0486
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."